Blog - Page 2029 of 5720

ThursdayMay 09, 2019 9:51 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Obtains Supply Agreement with British Columbia Liquor Distribution Branch

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, this morning announced that it has obtained a cannabis supply agreement with the BC Liquor Distribution Branch ("BCLDB"), under the brand BC Cannabis Stores. The agreement with British Columbia's public retailer of non-medical cannabis was negotiated in collaboration with Velvet Management Inc. “With very positive feedback on TGOD products from our British Columbia medical patients, we are excited to offer our premium certified organic products to the recreational market,” TGODF CEO Brian Athaide stated in the news release. “As our two Canadian production facilities come…

WednesdayMay 08, 2019 12:25 pm

Net Element Inc. (NASDAQ: NETE) Subsidiary Aptito Announces Sales and Support Partnership with HP Inc.

A strategic partnership with HP will enable Aptito to benefit from the tech giant’s massive global sales to deliver a full set of point-of-sale tools to small- and medium-sized clients The sales and support partnership will focus on a line of Android-based point-of-sale devices to enable access to affordable, cutting-edge payment technologies The innovative payment solutions market is anticipated to continue growing rapidly in 2019 and beyond, providing companies like Aptito with sustainable expansion opportunities Global technology and value-added solutions group Net Element Inc. (NASDAQ: NETE) subsidiary Aptito will be entering into a sales and support partnership with HP Inc.…

WednesdayMay 08, 2019 12:02 pm

VPR Brands, LP (VPRB) Pleased with Revenue Growth as Company Announces Year-End Financial Results

The popularity of vaping is driving analysts to predict a significant CAGR of well over 20 percent during the coming years VPR Brands’ vape accessory products, as well as its new cannabidiol product division, have helped the company record a 28 percent revenue increase for the past year The year also boosted VPR Brands’ operating loss into positive territory, as well as the company’s gross operating margin Atomization technology product innovator VPR Brands, LP (OTC: VPRB), celebrating a year of increasing revenues for its vaporizer and essential oils accessories, has announced its year-end financial results. “Much of 2018 was focused…

WednesdayMay 08, 2019 11:46 am

QualityStocksNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) to Sell Hemp CBD Products in Select Abercrombie & Fitch Locations

Lifestyle-oriented cannabis company Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured in a Bloomberg article earlier this week concerning the firm’s partnership with Abercrombie & Fitch Co. (NYSE: ANF). As noted in the article, Green Growth will sell its Seventh Sense Botanical Therapy body scrubs, bath bombs, cleansing oils, lotions and lip balms in 10 Abercrombie & Fitch stores in Massachusetts, California, Colorado and Nevada. The Bloomberg piece states that the Seventh Sense Botanical Therapy products are “made with CBD derived from hemp, which was legalized with the U.S. farm bill in December and is said by its…

WednesdayMay 08, 2019 11:42 am

Global Consortium Inc. (GCGX) Finalizing Financial Reports, Anticipates Registration Process for Nasdaq Listing

The company’s annual license for manufacturing recreational and medicinal cannabis products was recently renewed by the State of California GCGX’s cannabis mall is under construction in Sacramento, with a goal of beginning production of Infused Edibles products there by the end of the second quarter The company’s ultimate goal is to be listed and traded on the Nasdaq Diversified cannabis holding company Global Consortium Inc. (OTC: GCGX) remains committed to its goal of beginning the registration process to be listed and traded on the Nasdaq by mid- to late-June of this year, CEO Matthew Dwyer said during an investor conference…

WednesdayMay 08, 2019 11:23 am

Genprex Inc. (NASDAQ: GNPX) Aims to Reprogram the Course of Cancer with Gene Therapy Approach

Preclinical and clinical data indicate that Oncoprex immunogene therapy may be effective alone or in combination with targeted small molecule therapies; pre-clinical data also indicate potential effectiveness in combination with immunotherapies Lung cancer is the second-most common cancer and the leading cause of cancer deaths worldwide Genprex holds an exclusive license to more than 30 issued patents and several pending applications covering its platform technologies, including patents covering the therapeutic use of the TUSC2 tumor suppressor gene The value of the global immunotherapy drugs market is expected to surpass $385 billion by 2025, recording a CAGR of more than 14…

WednesdayMay 08, 2019 11:08 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Announces Strategic Investment in Califormulations LLC

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced its strategic investment in the newly-formed Califormulations LLC. Per the update, Califormulations will operate out of Columbus, Georgia, serving global branded companies with concept-to-shelf beverage commercialization support, including formulation development, technical services, in-house pilot scale production and contract manufacturing co-ordination. TGOD is expected to work with Califormulations to expedite the U.S. launch of TGOD-branded organic hemp-based CBD beverages, as permitted by local regulations. “We are incredibly excited to partner with Califormulations to further our development of hemp-based CBD beverage products,” Brian Athaide,…

WednesdayMay 08, 2019 10:59 am

Sugarmade Inc. (SGMD) Shipping Micropropagation Supplies for the Plant Clones Needed to Meet Demand from Kentucky Hemp Farmers

SGMD CEO says that the company is planning to “significantly expand” its operations to provide supplies for growers of hemp Jimmy Chan, CEO, estimates that hemp farmers in Kentucky will ultimately require “hundreds of millions” of hemp plant clones SGMD, focused on supplying hydroponic and cultivation products, has started to make deliveries of micropropagation supplies to farmers Sugarmade Inc. (OTCQB: SGMD), focused on hydroponic and hemp growing supplies, plans to significantly expand its supplies of hemp-cultivation products, specifically to farmers in Kentucky who are hard-pressed to meet booming demand. Jimmy Chan, CEO of SGMD, noted in a news release his…

WednesdayMay 08, 2019 10:54 am

QualityStocksNewsBreaks – SinglePoint Inc. (SING) Unveils National Distribution Program for Promising CBD Product Companies

Technology and investment company SinglePoint (OTCQB: SING) this morning introduced the new “Strategics” program, a strategic national distribution program that will offer qualified fast-growing CBD product companies a route to attain national retail distribution for their products. The Strategics program is offered in partnership with a national distribution company that has nearly $2 billion in annual sales to mass-market stores as well as various regional and national convenience stores. SinglePoint aims to identify and recruit burgeoning companies that manufacture or distribute CBD retail products that wish to have their products distributed nationally. Strategics program partner companies will have additional benefits…

WednesdayMay 08, 2019 10:11 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Retains Pharmaceutical Branding Agency to Oversee Lead Drug Candidate Naming Process

Clinical-stage, gene-therapy company Genprex (NASDAQ: GNPX) this morning announced that it has retained the services of leading pharmaceutical branding agency, Addison Whitney, representing the next step toward commercialization of its lead drug candidate. Utilizing its 28-year history, Addison Whitney will oversee the proprietary and non-proprietary drug naming process for the company’s drug candidate for non-small cell lung cancer, presently known as Oncoprex(TM) immunogene therapy. “Retaining Addison Whitney is an important step in bringing our drug candidate to market,” Genprex Chairman and CEO Rodney Varner stated in the news release. “Obtaining regulatory approval of proprietary and non-proprietary drug names is a…

Site Search

Company Search